Oscar Hoiting

Nijmegen, GE, NL 
Nijmegen, GE, NL 

Overview

Oscar Hoiting practices practicing medicine in Nijmegen, Netherlands.

His clinical expertise encompasses Aspergillosis and Flu.

He is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Nijmegen, GE, Netherlands
Other Locations
Franciscus Gasthuis and Vlietland Ziekenhuis
Rotterdam, ZH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Enrollment Status: Completed
Publish Date: March 23, 2020
Intervention Type: Other, Biological
Study Phase: Phase 2
View 1 Less Clinical Trial

13 Total Publications

Influenza-associated invasive aspergillosis in the ICU: a prospective, multicentre cohort study.
Influenza-associated invasive aspergillosis in the ICU: a prospective, multicentre cohort study.
Journal: Critical care (London, England)
Published: July 13, 2025

Frequently Asked Questions about Oscar Hoiting

Is Oscar Hoiting a top-rated expert for Aspergillosis?

MediFind is an objective health platform that identifies experts based on real-world data. Oscar Hoiting is classified as an Experienced expert for Aspergillosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Oscar Hoiting participate in research or clinical trials?

Yes. Oscar Hoiting has published 13 articles and abstracts on conditions like Aspergillosis. You can view a list of Oscar Hoiting's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hoiting's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile